RSCM

Rock Springs Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,921,487	Closed	-$14.7M	–	137
2022 Q1	$14.7M	Buy	4,921,487 +61,287	+1%	+$183K	0.37%	70
2021 Q4	$12.9M	Buy	4,860,200 +66,800	+1%	+$177K	0.3%	83
2021 Q3	$17.4M	Buy	4,793,400 +38,500	+0.8%	+$140K	0.37%	78
2021 Q2	$20.6M	Buy	4,754,900 +12,900	+0.3%	+$56K	0.41%	75
2021 Q1	$16.2M	Sell	4,742,000 -891	-0%	-$3.05K	0.35%	82
2020 Q4	$16.6M	Hold	4,742,891	–	–	0.35%	86
2020 Q3	$11.4M	Sell	4,742,891 -1,154,751	-20%	-$2.77M	0.29%	92
2020 Q2	$10.8M	Buy	5,897,642 +397,642	+7%	+$728K	0.3%	100
2020 Q1	$8.58M	Buy	5,500,000 +2,100	+0%	+$3.28K	0.35%	79
2019 Q4	$11.8M	Buy	5,497,900 +1,297,900	+31%	+$2.78M	0.37%	80
2019 Q3	$7.85M	Hold	4,200,000	–	–	0.31%	85
2019 Q2	$11M	Hold	4,200,000	–	–	0.4%	79
2019 Q1	$10.8M	Hold	4,200,000	–	–	0.42%	75
2018 Q4	$9.66M	Buy	4,200,000 +75,000	+2%	+$173K	0.46%	71
2018 Q3	$13.2M	Buy	4,125,000 +175,000	+4%	+$562K	0.48%	66
2018 Q2	$11.2M	Buy	3,950,000 +1,375,000	+53%	+$3.89M	0.43%	78
2018 Q1	$9.12M	Buy	2,575,000 +100,000	+4%	+$354K	0.39%	82
2017 Q4	$9.6M	Buy	2,475,000 +1,475,000	+148%	+$5.72M	0.44%	75
2017 Q3	$2.54M	Hold	1,000,000	–	–	0.12%	124
2017 Q2	$2.73M	Hold	1,000,000	–	–	0.14%	115
2017 Q1	$3.31M	Hold	1,000,000	–	–	0.19%	106
2016 Q4	$2.38M	Sell	1,000,000 -810,000	-45%	-$1.93M	0.16%	108
2016 Q3	$6.64M	Buy	1,810,000 +60,000	+3%	+$220K	0.42%	70
2016 Q2	$3.9M	Buy	1,750,000 +285,950	+20%	+$638K	0.29%	93
2016 Q1	$3.05M	Buy	1,464,050 +364,050	+33%	+$757K	0.26%	102
2015 Q4	$3.33M	Buy	+1,100,000	New	+$3.33M	0.25%	100